Fisher & Paykel Healthcare logo

FPH - Fisher & Paykel Healthcare News Story

NZD33.8 -0.8  -2.2%

Last Trade - 6:00am

Sector
Healthcare
Size
Large Cap
Market Cap £10.24bn
Enterprise Value £10.21bn
Revenue £824.5m
Position in Universe 30th / 1907

NZ's Fisher & Paykel sues Resmed in patent dispute

Tue 12th December, 2017 1:21am
Dec 12 (Reuters) - New Zealand's Fisher & Paykel Healthcare 
 FPH.NZ  filed a lawsuit in Australia on Tuesday against Resmed 
Inc  RMD.N  alleging the medical device manufacturer's 
respiratory treatment products violate four Fisher & Paykel 
patents.  
    Fisher & Paykel and California-based Resmed are engaged in 
patent disputes in several countries over medical devices used 
to treat respiratory conditions.  
    The company added its earnings forecast for fiscal 2018 
remained unchanged.  
 
 (Reporting by Christina Martin in Bengaluru; Editing by Stephen 
Coates) 
 ((christina.martin@thomsonreuters.com;)) 
 
Keywords: RESMED F&P HEALTHCARE/LAWSUIT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.